Does the absence of Lactobacillus species make elevated fecal secretory IgA more consistent with mucosal antigen reactivity?

The relationship between the gut microbiota and the mucosal immune system is highly dynamic, with specific bacterial species directing how immune markers like secretory IgA (sIgA) are interpreted.

Mechanistic pathways of mucosal tolerance

• Lactobacillus and dendritic cell priming: Under normal conditions, Lactobacillus species promote mucosal tolerance by conditioning local dendritic cells (DCs) into a tolerogenic phenotype characterized by high retinal dehydrogenase 2 (RALDH2) activity, low costimulatory molecules, and anti-inflammatory cytokine secretion.
• Loss of regulatory T (Treg) cells: This dendritic cell priming directly drives the differentiation and maintenance of Tregs. In the absence of Lactobacillus species, the crucial induction and function of these regulatory T cells are reduced, stripping the mucosal environment of vital tolerance-promoting signals.

Clinical implications of elevated secretory IgA

• Shift from tolerance to reactivity: During homeostasis, sIgA serves a non-inflammatory, protective role, complexing with bacteria like Lactobacillus rhamnosus to enhance the tolerogenic programming of mucosal DCs.
• Interpretation of elevated sIgA: When Lactobacillus is absent and tolerance-promoting signals are lost, the clinical meaning of elevated fecal sIgA shifts. Rather than indicating benign homeostatic coating, elevated sIgA in this depleted microenvironment is highly consistent with active mucosal antigen reactivity and localized inflammatory responses.

Bottom line

• Key takeaway: The absence of Lactobacillus impairs Treg-mediated tolerance, meaning that elevated fecal sIgA is clinically best interpreted as a sign of active, inflammatory mucosal antigen reactivity rather than healthy immune exclusion.